Review of CDC COVID-19 Vaccine Safety Research and Communications Meeting 3

The Committee to Review the CDC’s COVID-19 Vaccine Safety Research and Communications will host a two-hour public comment session on 11 October 2024.

Pre-registered attendees will have the opportunity to provide virtual public comments and suggestions on how to improve CDC’s vaccine safety research, and how to make vaccine safety and risk information better and easier to understand.

Comments and suggestions can pertain to vaccines used in emergencies, like COVID-19, and vaccines used in non-emergency situations (MMR, polio, etc.).

Learn more at the National Academies’ Review of CDC COVID-19 Vaccine Safety Research and Communications Meeting 3 (part 1).

Background

An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will evaluate the Centers for Disease Control and Prevention (CDC) Immunization Safety Office (ISO) systems, methods, and processes for monitoring COVID-19 vaccine safety during the U.S. COVID-19 vaccination program and provide recommendations for sustaining, maintaining, and strengthening CDC ISO current monitoring systems moving forward.

Specifically, the committee will assess the statistical and epidemiological methods and processes employed to detect and evaluate potential safety problems with the U.S. COVID-19 vaccines; catalog the findings from safety monitoring including pertinent positive and negative findings; and evaluate CDC external communications about its safety monitoring systems, the findings of COVID-19 vaccine safety monitoring, and vaccination and clinical guidance recommendations to healthcare professionals, public health officials, and the public.

Source: National Academies